Testing effectiveness (Phase 2)Study completedNCT02515942
What this trial is testing
CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)
Who this might be right for
Geographic Atrophy
Alcon Research 114